This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Phototherapy  • Dermatology, Other  • Alert me on articles by topic

Onset of Psoriasis During Treatment With TNF- Antagonists: A Report of 3 Cases

Ravi Ubriani, MD; Abby S. Van Voorhees, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Human recombinant soluble tumor necrosis factor (TNF) receptors (etanercept) and monoclonal antibodies to TNF- (infliximab and adalimumab) have been used successfully to treat a wide range of inflammatory conditions, including psoriasis. We report 1 case of plaque-type psoriasis and 2 cases of pustular psoriasis that developed in patients with no history of psoriasis who were being treated with TNF- antagonists.

Report of Cases

Case 1

A 65-year-old woman with a history of rheumatoid arthritis that had been treated for 4 years with infliximab and was well controlled with maintenance therapy (3 mg/kg every 8 weeks) was seen with a 7-month history of spreading erythematous plaques suggestive of psoriasis or a drug eruption (Figure 1). These plaques began on her legs and then progressed to involve her trunk and extremities. She had no personal or family history of psoriasis and denied any preceding upper respiratory infection.

Figure appears in full text version. . . . [Full Text of this Article]

Case 2

Case 3

Comment

AUTHOR INFORMATION